Manufacturing Cell Therapy Products – Current and Future Challenges

Wednesday, 27 June 2012 at 12:15

Add to Calendar ▼2012-06-27 12:15:002012-06-27 13:15:00Europe/LondonManufacturing Cell Therapy Products – Current and Future ChallengesSELECTBIOenquiries@selectbiosciences.com

Cell therapy products are currently manufactured in semi-manual processes. These are suitable to provide product for clinical trials and early commercialization phases. Beyond this, cell therapy products will have to be manufactured and processed in truly scalable systems and Lonza is developing such processes.  

Christian Bos, Executive Program Manager, Lonza AG

Christian Bos

Sorry, There is currently no biography for this presenter.